Phloroglucinol Derivatives Present an Antidepressant-like Effect in the Mice Tail Suspension Test (TST)
The antidepressant-like effects of phloroglucinol and seven synthetic related derivatives were investigated using the tail suspension test (TST) in mice. Depression is the most prevalent form of mental illness and is associated with significant disability and mortality [1] . Although several antidepressants are available, their adverse effects coupled with the poor response of patients to treatment [2] indicate the need for new drugs. Phloroglucinol (1) (Figure 1 ) and its derivatives comprise a group of natural molecules with important biological activities, including antimicrobial [3] and antidepressant effects [4] . Hyperforin (2) (Figure 1 ) is an acylphloroglucinol derivative isolated from Hypericum perforatum and has antidepressive activity, potentially as a result of its potent inhibition of serotonin, dopamine, noradrenaline, GABA and L-glutamate reuptake in vitro [5] .
Recently, we demonstrated that uliginosin B (3) (Figure 1 ), which is a dimeric phloroglucinol derivative obtained from H. polyanthemum and H. caprifoliatum, native plants of South Brazil, exerts an antidepressant-like effect in rodents through a mechanism that differs from that of classical antidepressants [6, 7] . Uliginosin B (3) was able to inhibit the synaptosomal uptake of dopamine (IC 50 = 90 ± 38 nM), serotonin (IC 50 = 252 ± 13 nM) and noradrenalin (280 ± 48 nM), but did not bind to any of the tested monoamine transporters [7] . Acylated dimeric phloroglucinol derivatives with antidepressant-like activity also occur in fern species from Argentina, including Elaphoglossum crassipes [8] . Together, these data strongly suggest that phloroglucinol derivatives may represent a promising new molecular scaffold for the development of antidepressant drugs. In this study, we designed and synthesized phloroglucinol derivatives containing acyl groups using the structural simplification approach based on uliginosin B (3) to identify new phloroglucinol derivatives with an antidepressant-like effect. Phloroglucinol and its seven derivatives were tested in mice using a simple and classical model for screening antidepressant drugs, the tail suspension test [9] . The seven derivatives 4-10 were obtained as shown in Scheme 1. Compounds 4-7 were obtained from phloroglucinol (1) and the corresponding acid through an aromatic acylation catalyzed by BF 3 .Et 2 O [10, 11] . Each reaction gave a pair of derivatives, the corresponding mono and diacylated compounds, which were isolated in moderate yield after silica gel column chromatography. Compound 8 [12] was obtained through alkylation of phloroglucinol (1) with 3,3-dimethylallyl bromide in the presence of K 2 CO 3 [13, 14] in 80% yield after purification by column chromatography using cyclohexane as the eluent. The dimeric compounds 9 and 10 [15] were synthesized through intermolecular condensation of monomers 5 or 7 in basic medium (KOH 1%) in the presence of formaldehyde [10, 11] . These derivatives were obtained in good yields (80% and 71%, respectively) after acidification of the crude mixture, subsequent extraction with ethyl acetate and purification. The structures of the compounds were confirmed by 1 H, 13 C NMR and mass spectral data.
Compounds were tested in mice using the TST for screening antidepressant drugs [9] . Considering phloroglucinol (1) did not alter the immobility time in the TST compared with the vehicletreated group (143.5 s), efforts were made to enhance its activity through chemical modification. We observed that compounds 4 and 
5
, with an isobutyryl substituent, showed immobility times of 132 and 93 seconds, respectively, in the TST (Figure 3) . Only compound 5, possessing two substituents in its phenolic ring, showed a significant difference compared with the vehicle-treated group.
Additionally, both compounds 6 and 7, with acyl groups on the phloroglucinol core, significantly reduced immobility times in the TST compared with the vehicle-treated group, with immobility times of 120.5 and 123.5 seconds, respectively. Compound 8, with two new rings in its structure as a result of isoprenyl group cyclization and no free phenolic groups, did not alter the immobility time (154 seconds) in the TST compared with the vehicle-treated group. Finally, the dimeric molecules 9 and 10 significantly reduced the immobility times in the TST (109.0 and 113.5 seconds) compared with the vehicle-treated group (Figure 3 ). The OFT was performed to evaluate possible unspecific effects on the spontaneous locomotor activity from those compounds active in the TST. None of the tested compounds altered locomotion in the OFT when compared with the saline-treated group (Table 1) .
Seven compounds were synthesized following the structural simplification approach using uliginosin B as the prototype. The challenge was to develop synthetic protocols that would provide compounds in moderate to good yields with few by-products. These new compounds together with phloroglucinol were submitted to the mice tail suspension test (TST). Compounds 5, 6, 7, 9 and 10 showed good antidepressant-like activity in TST without altering locomotion in the OFT compared with a saline control.
Our results demonstrated that small acyl groups, including those in bigger molecules, such as compounds 9 and 10, increased the antidepressant-like activity in TST when added to the phloroglucinol core. In this paper, we have presented a straightforward and successful strategy to obtain simple and active molecules. As far as we know, it is shown for the first time the antidepressant activity of these molecules. They can be considered lead compounds in the search for new antidepressant drugs.
Experimental

General:
1 H and 13 C nuclear magnetic resonance (NMR) spectra were recorded using Anasazi Eft-60, Varian 300 and 500
Antidepressant activity of phloroglucinol derivatives
Natural Product Communications Vol. 9 (5) 2014 673 spectrometers. MS were obtained using a Micromass-Waters Q-TOF Ultima with electrospray ionization and an LC-MS Bruker Daltonics MicroTOF mass spectrometer.
General procedure for the synthesis of 2,4,6-trihydroxyphenones (4-7):
Phloroglucinol was added to a mixture of the corresponding acid and 40% BF 3 .Et 2 O. The reaction mixture was stirred at 80°C for 4 h. The crude reaction was treated with 4 M HCl, until an acidic pH was reached. The aqueous phase was extracted with ethyl acetate (3 x 20 mL) and purified by preparative TLC using a mixture of cyclohexane and ethyl acetate (1:1) as the eluent. The solvent was evaporated under vacuum to obtain the pure compounds. -1-(2,4,6-trihydroxyphenyl) 2,2,6,6,10,10-Hexamethyl-3,4,6,7,8,10,11,12-octahydro-2H-1,5,9 trioxatriphenylene (8): Phloroglucinol (100 mg, 0.79 mmol) was added to a suspension of potassium carbonate (65 mg, 0.6 equiv.) in anhydrous acetone (10 mL). The reaction mixture was kept for 15 min and 3,3-dimethylalyll bromide (353 mg, 3 equiv.) was added to anhydrous acetone (3 mL). The reaction was refluxed for 24 h. The solid was filtered off, the solvent evaporated and the residue purified by CC using cyclohexane as eluent. General procedure for the synthesis of dimeric compounds (9-10): To a suspension of compound 5 or 7 in 1% KOH solution was added formaldehyde. The reaction mixture was maintained for 1 h at room temperature. The crude reaction was acidified with 4 M HCl to pH 4, extracted with acetyl acetate (3x5 mL), and purified by silica gel CC using a mixture of cyclohexane and ethyl acetate as eluent. -1-[2,4,6-trihydroxy-3-(2-methylpropanoyl) 
2-Methyl
Tail suspension test (TST):
This was conducted according to Steru et al. [9] , with minor modifications [17] . Mice were adapted to the laboratory conditions 1 h before the test. The animals, under acoustic and visual isolation, were suspended by the tail 60 cm above the floor using adhesive tape (1 cm from the tip of the end) in a dimly light room. Immobility time was recorded (in seconds) during the last 4 min of a total 6 min session [18] by human observers blind to the treatment. Mice were considered immobile when they hung passively and completely motionless.
Open-field test (OFT): Animals were individually placed in the center of an acrylic box (40×30×30 cm) with the floor divided into 24 equal squares. The number of squares crossed with 4 paws (crossing) was recorded in a 6 min session by human observers blind to the treatment. The apparatus was cleaned with 10% ethanol after each test.
Statistical analysis: Data were analyzed by the Kruskal-Wallis test, followed by Dunn's Method (P<0.05) using Sigma Stat software 2.03 (Jandel Scientific Corporation).
